AGRl Stock Overview
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Assura Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.42 |
52 Week High | UK£0.53 |
52 Week Low | UK£0.39 |
Beta | 0.30 |
1 Month Change | 2.08% |
3 Month Change | -0.12% |
1 Year Change | -18.11% |
3 Year Change | -41.81% |
5 Year Change | -30.82% |
Change since IPO | -30.65% |
Recent News & Updates
Recent updates
Shareholder Returns
AGRl | GB Health Care REITs | GB Market | |
---|---|---|---|
7D | 1.0% | 1.4% | 2.3% |
1Y | -18.1% | -14.5% | 5.5% |
Return vs Industry: AGRl underperformed the UK Health Care REITs industry which returned -14.6% over the past year.
Return vs Market: AGRl underperformed the UK Market which returned 5.8% over the past year.
Price Volatility
AGRl volatility | |
---|---|
AGRl Average Weekly Movement | 3.0% |
Health Care REITs Industry Average Movement | 2.7% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: AGRl has not had significant price volatility in the past 3 months.
Volatility Over Time: AGRl's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 86 | Jonathan Murphy | www.assuraplc.com |
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health.
Assura Plc Fundamentals Summary
AGRl fundamental statistics | |
---|---|
Market cap | UK£1.27b |
Earnings (TTM) | -UK£167.90m |
Revenue (TTM) | UK£152.60m |
8.3x
P/S Ratio-7.5x
P/E RatioIs AGRl overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AGRl income statement (TTM) | |
---|---|
Revenue | UK£152.60m |
Cost of Revenue | UK£13.80m |
Gross Profit | UK£138.80m |
Other Expenses | UK£306.70m |
Earnings | -UK£167.90m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 21, 2024
Earnings per share (EPS) | -0.056 |
Gross Margin | 90.96% |
Net Profit Margin | -110.03% |
Debt/Equity Ratio | 81.8% |
How did AGRl perform over the long term?
See historical performance and comparison